The IIT Study of Evaluation of P-IL-2 Single Agent and With Anti-PD-1
Zhejiang University
Zhejiang University
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Shanghai Yunying Medical Technology
Jules Bordet Institute
SpeciCare
MultiVir, Inc.
Merrimack Pharmaceuticals
Optimata Ltd.
The University of Texas Health Science Center, Houston